Manhattan Associates INC Schedule 13G passive stakes

FMR LLC, through its affiliates, has reported a beneficial ownership of 6.1% of Manhattan Associates Inc.'s common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.9% of Manhattan Associates Inc. common stock as of March 31, 2026.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported a beneficial ownership of 5.28% in Manhattan Associates Inc. common stock as of March 31, 2026.

Vanguard Capital Management has reported beneficial ownership of 5.24% of Manhattan Associates Inc.'s common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 6.49% of Manhattan Associates Inc.'s common stock as of March 31, 2026.

The Vanguard Group has amended its Schedule 13G filing for Manhattan Associates Inc., reporting 0% beneficial ownership following an internal realignment.

FMR LLC and its affiliates, including Abigail P. Johnson, reported a 5.1% beneficial ownership stake in Manhattan Associates Inc. as of December 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 10.2% beneficial ownership stake in Manhattan Associates Inc. as of June 30, 2025.

Investment adviser AllianceBernstein L.P. has disclosed a 3.7% beneficial ownership stake in Manhattan Associates Inc. common stock, held for passive investment purposes.

BlackRock, Inc. has filed an Amendment No. 21 to Schedule 13G, confirming its passive beneficial ownership of 12.1% of Manhattan Associates Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 14.1% beneficial ownership stake in Manhattan Associates Inc. as of December 31, 2024.